Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children.

Patel SS, Bizjajeva S, Lindert K, Heijnen E, Oberye J.

Int J Infect Dis. 2019 Aug;85S:S26-S38. doi: 10.1016/j.ijid.2019.05.009. Epub 2019 May 13.

2.

MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications.

Patel SS, Bizjajeva S, Heijnen E, Oberye J.

Int J Infect Dis. 2019 Aug;85S:S18-S25. doi: 10.1016/j.ijid.2019.04.023. Epub 2019 Apr 30.

3.

Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience.

Nicolay U, Heijnen E, Nacci P, Patriarca PA, Leav B.

Int J Infect Dis. 2019 Aug;85S:S1-S9. doi: 10.1016/j.ijid.2019.03.026. Epub 2019 Mar 26.

4.

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older.

Lindert K, Leav B, Heijnen E, Barrett J, Nicolay U.

Int J Infect Dis. 2019 Aug;85S:S10-S17. doi: 10.1016/j.ijid.2019.03.020. Epub 2019 Mar 20.

5.

Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD® and VANTAFLU® in South Korean Subjects Aged ≥65 Years.

Yoo BW, Kim CO, Izu A, Arora AK, Heijnen E.

Infect Chemother. 2018 Dec;50(4):301-310. doi: 10.3947/ic.2018.50.4.301.

6.

A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults.

Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC.

Infection. 2019 Feb;47(1):105-109. doi: 10.1007/s15010-018-1233-2. Epub 2018 Oct 8.

PMID:
30298473
7.

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.

Statler VA, Albano FR, Airey J, Sawlwin DC, Graves Jones A, Matassa V, Heijnen E, Edelman J, Marshall GS.

Vaccine. 2019 Jan 7;37(2):343-351. doi: 10.1016/j.vaccine.2018.07.036. Epub 2018 Jul 26.

8.

Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.

Vesikari T, Kirstein J, Devota Go G, Leav B, Ruzycky ME, Isakov L, de Bruijn M, Oberye J, Heijnen E.

Lancet Respir Med. 2018 May;6(5):345-356. doi: 10.1016/S2213-2600(18)30108-5. Epub 2018 Apr 6.

PMID:
29631857
9.

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.

Cruz-Valdez A, Valdez-Zapata G, Patel SS, Castelli FV, Garcia MG, Jansen WT, Arora AK, Heijnen E.

Hum Vaccin Immunother. 2018 Feb 1;14(2):386-395. doi: 10.1080/21645515.2017.1373227. Epub 2018 Jan 3.

10.

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents.

Saez-Llorens X, Aguilera Vaca DC, Abarca K, Maho E, Graña MG, Heijnen E, Smolenov I, Dull PM.

Hum Vaccin Immunother. 2015;11(6):1507-17. doi: 10.1080/21645515.2015.1029686.

11.

A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.

Qiao J, Lu G, Zhang HW, Chen H, Ma C, Olofsson JI, Witjes H, Heijnen E, Mannaerts B.

Gynecol Endocrinol. 2012 Oct;28(10):800-4. doi: 10.3109/09513590.2012.665103. Epub 2012 Mar 20.

PMID:
22429192
12.

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.

Norman RJ, Zegers-Hochschild F, Salle BS, Elbers J, Heijnen E, Marintcheva-Petrova M, Mannaerts B; Trust Investigators.

Hum Reprod. 2011 Aug;26(8):2200-8. doi: 10.1093/humrep/der163. Epub 2011 May 27.

13.

Purpura in a patient receiving vancomycin: a leukoclastic vasculitis?

Heijnen EB, Bentala M, van der Meer NJ.

J Cardiothorac Vasc Anesth. 2011 Apr;25(2):390-1. doi: 10.1053/j.jvca.2010.02.027. Epub 2010 Apr 27. No abstract available.

PMID:
20427206
14.

The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.

Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Baart EB, Hohmann FP, Fauser BC, Broekmans FJ.

Hum Reprod Update. 2009 Jan-Feb;15(1):5-12. doi: 10.1093/humupd/dmn053. Review.

PMID:
19091754
15.

Why do couples drop-out from IVF treatment? A prospective cohort study.

Verberg MF, Eijkemans MJ, Heijnen EM, Broekmans FJ, de Klerk C, Fauser BC, Macklon NS.

Hum Reprod. 2008 Sep;23(9):2050-5. doi: 10.1093/humrep/den219. Epub 2008 Jun 10.

PMID:
18544578
16.

[Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation].

Heijnen EM, Eijkemans MJ, de Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, te Velde ER, Macklon NS, Fauser BC.

Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):809-16. Dutch.

PMID:
18491824
17.

Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.

Polinder S, Heijnen EM, Macklon NS, Habbema JD, Fauser BJ, Eijkemans MJ.

Hum Reprod. 2008 Feb;23(2):316-23. Epub 2007 Nov 22.

PMID:
18033807
18.

Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle.

de Klerk C, Hunfeld JA, Heijnen EM, Eijkemans MJ, Fauser BC, Passchier J, Macklon NS.

Hum Reprod. 2008 Jan;23(1):112-6. Epub 2007 Nov 5.

PMID:
17984173
19.

Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF.

Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans FJ.

Fertil Steril. 2008 May;89(5):1159-65. Epub 2007 Aug 8.

PMID:
17686477
20.

The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy.

de Klerk C, Macklon NS, Heijnen EM, Eijkemans MJ, Fauser BC, Passchier J, Hunfeld JA.

Hum Reprod. 2007 Sep;22(9):2554-8. Epub 2007 Jun 23.

PMID:
17586832
21.

Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.

Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans FJ.

Hum Reprod. 2007 Jul;22(7):1919-24. Epub 2007 May 7.

PMID:
17485438
22.

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.

Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BC.

Lancet. 2007 Mar 3;369(9563):743-749. doi: 10.1016/S0140-6736(07)60360-2.

PMID:
17336650
23.

ART: iatrogenic multiple pregnancy?

Verberg MF, Macklon NS, Heijnen EM, Fauser BC.

Best Pract Res Clin Obstet Gynaecol. 2007 Feb;21(1):129-43. Epub 2006 Oct 30. Review.

PMID:
17074535
24.

Prevention of multiple pregnancies after IVF in women 38 and older: a randomized study.

Heijnen EM, Klinkert ER, Schmoutziguer AP, Eijkemans MJ, te Velde ER, Broekmans FJ.

Reprod Biomed Online. 2006 Sep;13(3):386-93.

PMID:
16984771
25.

The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF.

de Klerk C, Heijnen EM, Macklon NS, Duivenvoorden HJ, Fauser BC, Passchier J, Hunfeld JA.

Hum Reprod. 2006 Mar;21(3):721-7. Epub 2005 Nov 25.

PMID:
16311295
27.

A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.

Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC.

Hum Reprod Update. 2006 Jan-Feb;12(1):13-21. Epub 2005 Aug 25.

PMID:
16123051
28.

What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment.

Heijnen EM, Macklon NS, Fauser BC.

Hum Reprod. 2004 Sep;19(9):1936-8. Epub 2004 Jun 24. Review.

PMID:
15217998
29.

Aerosol delivery from spacers in wheezy infants: a daily life study.

Janssens HM, Heijnen EM, de Jong VM, Hop WC, Holland WP, de Jongste JC, Tiddens HA.

Eur Respir J. 2000 Nov;16(5):850-6.

Supplemental Content

Loading ...
Support Center